Good Pharma Scorecard

We rank bio-pharmaceutical companies and new drugs on ethics and public health performance criteria, focusing on issues that are critical to patients.

The Good Pharma Scorecard ranks companies and new medicines on their clinical trial transparency and data-sharing performance, taking into account ethics and legal standards. Subsequent versions of the scorecard will also evaluate the integrity of clinical trial designs, the accessibility of medicines, drug marketing practices, and other ethics and human rights issues.

Clinical Trial Transparency and Data Sharing
Are Important Because:

Transparency is key to protecting and respecting research participants and  users of medicines and vaccines

Evidenced based medicine requires all evidence to be in the public domain

Being able to learn from what other scientists have already done- both accomplishments and failures- stimulates innovation and ultimately the delivery of lifesaving results.

Transparency is key to maximizing the value of generated trial data and people’s participation in trials

Opacity can drive up costs of research and care

Transparency and data-sharing enable validation and replication of study findings

Rankings

View Good Pharma Scorecard rankings by

Drug
Sponsor/Co-Sponsor
Indication
Drug
Sponsor/
Co-Sponsor
Indication
Transparency
Score
# 1 Belsomra Merck Sharp & Dohme Insomnia
Merck Sharp & Dohme
Insomnia
# 1 Cerdelga Sanofi / Genzyme Gaucher Disease
Sanofi / Genzyme
Gaucher Disease
# 1 Esbriet Roche / Genentech Pulmonary Fibrosis
Roche / Genentech
Pulmonary Fibrosis
# 1 Invokamet Johnson & Johnson / Janssen Type 2 Diabetes
Johnson & Johnson / Janssen
Type 2 Diabetes
# 1 Lynparza AstraZeneca Ovarian Cancer
AstraZeneca
Ovarian Cancer
# 1 Movantik AstraZeneca Constipation
AstraZeneca
Constipation
# 1 Xtoro Novartis / Alcon Otitis Externa
Novartis / Alcon
Otitis Externa
# 1 Zerbaxa Merck & Co / Cubist Urinary & Abdominal Infections
Merck & Co / Cubist
Urinary & Abdominal Infections
# 1 Zontivity Merck Sharp & Dohme Thrombotic Cardiovascular Events
Merck Sharp & Dohme
Thrombotic Cardiovascular Events
# 1 Zykadia Novartis Lung Cancer
Novartis
Lung Cancer
100% Median Median score

Median: 100%

# 11 Viekira Pak AbbVie Hepatitis C
AbbVie
Hepatitis C
# 12 Otezla Celgene Psoriasis
Celgene
Psoriasis
# 13 Xigduo XR AstraZeneca Type 2 Diabetes
AstraZeneca
Type 2 Diabetes
# 14 Sivextro Merck & Co / Cubist Skin Infection
Merck & Co / Cubist
Skin Infection
# 14 Zydelig Gilead Leukemia
Gilead
Leukemia
# 16 Harvoni Gilead Hepatitis C
Gilead
Hepatitis C
# 17 Farxiga AstraZeneca Type 2 Diabetes
AstraZeneca
Type 2 Diabetes
# 18 Dalvance Allergan / Durata Skin Infection
Allergan / Durata
Skin Infection
# 19 Jublia Valeant / Dow Onychomycosis
Valeant / Dow
Onychomycosis